Jade Biosciences JBIO
NASDAQ JBIO
$14.91 -0.22 (-1.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Price to Sales (2021 - 2026)

Updated

Analysis

Jade Biosciences (JBIO) Price to Sales (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Jade Biosciences 947.62 Mn -360.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.02
Mar 31, 2026 67.51
Dec 31, 2025 110.94
Sep 30, 2025 47.08
Jun 30, 2025 79.21
Mar 31, 2025 691.37
Dec 31, 2024 606.31
Sep 30, 2024 428.51
Jun 30, 2024 264.26
Mar 31, 2024 4,612.43
Dec 31, 2023 3,698.81
Sep 30, 2023 2,541.39
Jun 30, 2023 4,222.11
Dec 31, 2022 200.64
Sep 30, 2022 113.34
Jun 30, 2022 106.92
Mar 31, 2022 117.65
Dec 31, 2021 78,045.63
Sep 30, 2021 995,808.40
API Access

Jade Biosciences Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=JBIO&period=max&api_key=YOUR_API_KEY